Polycystic Ovary Syndrome Shopping
Ovary
Website Links For
Polycystic
 

Information About

Polycystic Ovary Syndrome




  ICD10 E282
  ICD9


Polycystic ovary syndrome ('''PCOS''', also known clinically as '''Stein-Leventhal syndrome'''), is an Endocrine Disorder that affects 5–10% of women. It occurs amongst all races and nationalities, is the most common hormonal disorder among women of reproductive age, and is a leading cause of Infertility . The symptoms and severity of the syndrome vary greatly between women. While the causes are unknown, Insulin Resistance (often secondary to Obesity ) is heavily correlated with PCOS.


NOMENCLATURE

Other names for this disorder include


DEFINITION

Two definitions are commonly used:
#In 1990 a consensus workshop sponsored by the NIH / NICHD suggested that a patient has PCOS if she has (1) signs of Androgen excess (clinical or biochemical), (2) Oligoovulation , and (3) other entities are excluded that would cause polycystic ovaries.
#In 2003 a consensus workshop sponsored by and/or Anovulation , (2) excess androgen activity, (3) polycystic ovaries (by Gynecologic Ultrasonography ), and other causes of PCOS are excluded.

The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, whereas in the NIH/NICHD definition androgen excess is a prerequisite. Critics maintain that findings obtained from the study of patients with androgen excess cannot necessarily be extrapolated to patients without androgen excess.


SIGNS AND SYMPTOMS

Common symptoms of PCOS include

Signs are:


RISKS

Women with PCOS are at risk for the following:

Some data suggest that women with PCOS have a higher risk of Miscarriage . Also, many women with PCOS have a difficult time conceiving because of their irregular cycles and lack of ovulation. However, it is possible for these women to have normal pregnancies with the aid of medication and diet.


DIAGNOSIS

It is vital to note that not all women with PCOS have polycystic ovaries, nor do all women with ovarian cysts have PCOS; although a Pelvic Ultrasound is a major diagnostic tool, it is not the only one. Diagnosis can be difficult, particularly because of the wide range of symptoms and the variability in presentation (which is why this disorder is characterized as a syndrome rather than a disease).
There is a lot of controversy about the appropriate testing:

The role of other tests is more controversial, including


DIFFERENTIAL DIAGNOSIS

Other causes of irregular or absent menstruation and hirsutism, such as Congenital Adrenal Hyperplasia , Cushing's Syndrome , Hyperprolactinemia , and other pituitary or adrenal disorders, should be investigated.


PATHOGENESIS

PCOS develops when the ovaries are stimulated to produce excessive amounts of male hormones (androgens), particularly testosterone, either through the release of excessive luteinizing hormone (LH) by the pituitary gland or through high levels of insulin in the blood (hyperinsulinaemia) in women whose ovaries are sensitive to this stimulus.

This syndrome acquired its most widely used name because a common symptom is multiple (poly) ovarian Cyst s. These form where egg follicles matured but were never released from the Ovary because of abnormal hormone levels. These generally take on a 'string of pearls' appearance. The condition was first described in 1935 by Dr. Stein and Dr. Leventhal, hence its original name of Stein-Leventhal syndrome.

Although the cause of PCOS is not known, research to date suggests that Obesity is a prime indicator. It may have a genetic predisposition, and further research into this possibility is taking place. No specific gene has been identified, and it is thought that many genes could contribute to the development of PCOS.

A majority of patients with PCOS - some investigators say all - have insulin resistance. Their elevated insulin levels contribute to or cause the abnormalities seen in the hypothalamic-pituitary-ovarian axis that lead to PCOS. Specifically, hyperinsulinemia increases GnRH pulse frequency, LH over FSH dominance, increased ovarian androgen production, decreased follicular maturation, and decreased SHBG binding; all these steps lead to the development of PCOS. Insulin resistance is a common finding in obese people.


TREATMENT

Medical treatment of PCOS used to be directed mainly at the symptoms (ovarian and adrenal suppression and Anti-androgen therapy) and at restoring Ovulation . Some medications used for these purposes are

Recent research suggests that the hydrochloride (Glucophage®), Pioglitazone hydrochloride (Actos®), and Rosiglitazone maleate (Avandia®) helpful, and ovulation may resume when they use these agents. Many women report that Metformin use is associated with upset stomach, diarrhea, and weight-loss. Both symptoms and weight loss appear to be less with the extended release versions. Most published studies use either generic metformin or the regular, non-extended release version. Starting with a lower dosage and gradually increasing the dosage over 2-3 weeks and taking the medication toward the end of a meal may reduce side effects. The use of Basal Body Temperature or BBT charts is an effective way to follow progress. It may take up to six months to see results, but when combined with exercise and a Low-glycemic Diet up to 85% will improve menstrual cycle regularity and ovulation.

Low-carbohydrate Diet s and sustained regular exercise are also beneficial. Also, initial research suggests that the risk of miscarriage is significantly reduced when Metformin is taken throughout pregnancy (9% as opposed to as much as 45%); however, further research is needed in this area.

For patients who do not respond to these and related medications or procedures, the polycystic ovaries can be treated with surgical procedures such as


REFERENCE


Spirinolactone is a potassium sparing diuretic and does not block the affects of androgen as implied by the above text. Finasteride however is a 5-alpha reductase inhibitor and so does prevent androgen actions by preventing testosterone being converted to the more bioactive, dihydrotestosterone form.


EXTERNAL LINKS


Scientific information





Support groups